Endocrine therapy agents used in the treatment of breast cancer include SERMs (selective estrogen receptor modulators), SERDs (selective estrogen receptor degraders), and SAIs (selective aromatase inhibitors). The gene discussed is CYP19A1; the disease is breast carcinoma.